Pretreatment with IL-1β enhances proliferation and chondrogenic potential of synovium-derived mesenchymal stem cells

This publication has 43 references indexed in Scilit:

• Standardized butanol fraction of WIN-34B suppresses cartilage destruction via inhibited production of matrix metalloproteinase and inflammatory mediator in osteoarthritis human cartilage explants culture and chondrocytes
  BMC Complementary and Alternative Medicine, 2012
• Role of Interleukin-1 Inhibitors in Osteoarthritis
  Drugs & Aging, 2012
• Engineered Cartilage Maturation Regulates Cytokine Production and Interleukin-1β Response
  Clinical Orthopaedics and Related Research, 2011
• Pretreatment with Interferon-γ Enhances the Therapeutic Activity of Mesenchymal Stromal Cells in Animal Models of Colitis
  Stem Cells, 2011
• Interferon-γ Regulates the Proliferation and Differentiation of Mesenchymal Stem Cells via Activation of Indoleamine 2,3 Dioxygenase (IDO)
  PLOS ONE, 2011
• Interleukin‐6 maintains bone marrow‐derived mesenchymal stem cell stemness by an ERK1/2‐dependent mechanism
  Journal of Cellular Biochemistry, 2009
• Oversulfated chondroitin sulfate‐E binds to BMP‐4 and enhances osteoblast differentiation
  Journal of Cellular Physiology, 2008
• Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle
  Cell and tissue research, 2006
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
  Cytotherapy, 2006
• Interleukin-1β Induces Different Gene Expression of Stromelysin, Aggrecan and Tumor-Necrosis-Factor-Stimulated Gene 6 in Human Osteoarthritic Chondrocytes in vitro
  Pathobiology, 2000